Role of MRI in Active Surveillance of Prostate Cancer

被引:0
|
作者
Chappidi, Meera R. [1 ]
Lin, Daniel W. [1 ]
Westphalen, Antonio C. [1 ,2 ,3 ]
机构
[1] Univ Washington, Sch Med, Dept Urol, Seattle, WA USA
[2] Univ Washington, Sch Med, Dept Radiol, 1959 NE Pacific St, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA USA
关键词
CLINICAL STAGE; MEN; BIOPSY; PROGRESSION; OUTCOMES;
D O I
10.1053/j.sult.2024.11.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Magnetic resonance imaging (MRI) plays an important role in the management of patients with prostate cancer on active surveillance. In this review, we will explore the incorporation of MRI into active surveillance protocols, detailing its impact on clinical decision-making and patient management and discussing how it aligns with current guidelines and practice patterns. The role of MRI in this patient population continues to evolve over time, and we will discuss some of the recent advancements in the field and highlight potential areas for future research endeavors.
引用
收藏
页码:31 / 44
页数:14
相关论文
共 50 条
  • [31] Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
    Giganti, Francesco
    Stabile, Armando
    Stavrinides, Vasilis
    Osinibi, Elizabeth
    Retter, Adam
    Orczyk, Clement
    Panebianco, Valeria
    Trock, Bruce J.
    Freeman, Alex
    Haider, Aiman
    Punwani, Shonit
    Allen, Clare
    Kirkham, Alex
    Emberton, Mark
    Moore, Caroline M.
    EUROPEAN RADIOLOGY, 2021, 31 (03) : 1644 - 1655
  • [32] Optimization of follow up in prostate cancer active surveillance
    Celma Domenech, Ana
    Planos Morin, Jacques
    Morote Robles, Juan
    ARCHIVOS ESPANOLES DE UROLOGIA, 2014, 67 (05): : 442 - 451
  • [33] Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice
    Pastor-Navarro, Belen
    Rubio-Briones, Jose
    Borque-Fernando, Angel
    Esteban, Luis M.
    Dominguez-Escrig, Jose Luis
    Lopez-Guerrero, Jose Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [34] Active surveillance for localized prostate cancer
    Staerman, F.
    Peyromaure, M.
    Irani, J.
    Gaschignard, N.
    Mottet, N.
    Soulie, M.
    Salomon, L.
    PROGRES EN UROLOGIE, 2011, 21 (07): : 448 - 454
  • [35] Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols
    Kates, Max
    Tosoian, Jeffrey J.
    Trock, Bruce J.
    Feng, Zhaoyong
    Carter, H. Ballentine
    Partin, Alan W.
    BJU INTERNATIONAL, 2015, 115 (02) : 216 - 222
  • [36] The inconveniences of active surveillance in prostate cancer
    Sanchez-de-Badajoz, E.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (02): : 69 - 71
  • [37] Active Surveillance for Low-Risk Prostate Cancer
    Klotz, Laurence
    CURRENT UROLOGY REPORTS, 2015, 16 (04) : 1 - 10
  • [38] Understanding Active Surveillance for Prostate Cancer
    Lai, Lillian Y.
    Shahinian, Vahakn B.
    Oerline, Mary K.
    Kaufman, Samuel R.
    Skolarus, Ted A.
    Caram, Megan E., V
    Hollenbeck, Brent K.
    JCO ONCOLOGY PRACTICE, 2021, 17 (11) : 678 - +
  • [39] MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
    Glaser, Zachary A.
    Porter, Kristin K.
    Thomas, John V.
    Gordetsky, Jennifer B.
    Rais-Bahrami, Soroush
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S411 - S419
  • [40] Impact of prostate volume on the active surveillance in prostate cancer
    Beaujouan, Florent
    Bertherat, Walter
    Hammoudi, Zakaria
    Chicaud, Marie
    Descazeaud, Aurelien
    JOURNAL OF CLINICAL UROLOGY, 2024,